According to Beam Therapeutics 's latest financial reports the company's current EPS (TTM) is -4,31ย โฌ. In 2022 the company made an earnings per share (EPS) of -3,94ย โฌ an increase over its 2021 EPS that were of -5,68ย โฌ.